For research use only. Not for therapeutic Use.
Apomorphine hydrochloride hemihydrate (CAT: I003503) is a non-selective dopamine agonist that activates both D1-like and D2-like receptors in the brain. It exhibits some preference for D2-like receptors, which include D2, D3, and D4 receptors. By stimulating these receptors, apomorphine mimics the action of dopamine, a neurotransmitter involved in regulating movement, cognition, and mood. In the context of Parkinson’s disease, apomorphine’s activation of dopamine receptors helps to compensate for the loss of dopamine-producing cells in the brain, thereby improving motor symptoms associated with the disease.
Catalog Number | I003503 |
CAS Number | 41372-20-7 |
Synonyms | (R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride hydrate |
Molecular Formula | C17H20ClNO3 |
Purity | ≥95% |
Target | Dopamine Receptor |
Solubility | DMSO: ≥ 31 mg/mL |
Storage | Store at -20C |
SMILES | CN1CCC2=C([C@@]1([H])CC3=C4C(O)=C(O)C=C3)C4=CC=C2.Cl.O |
Reference | <p> |